<ARTICLE> 5
<LEGEND>
This Schedule contains summary financial information extracted from the
condensed financial statements of Cytomedix, Inc. for the three months ended
September 30, 2000 (unaudited) and is qualified in its entirety by reference to
such financial statements.
</LEGEND>


                             
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                              JAN-1-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                       4,198,266
<SECURITIES>                                         0
<RECEIVABLES>                                   81,247
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                             4,811,566
<PP&E>                                         544,903
<DEPRECIATION>                                (50,872)
<TOTAL-ASSETS>                               5,456,164
<CURRENT-LIABILITIES>                          724,649
<BONDS>                                         45,397
<PREFERRED-MANDATORY>                        1,625,000
<PREFERRED>                                        512
<COMMON>                                         1,054
<OTHER-SE>                                   3,059,552
<TOTAL-LIABILITY-AND-EQUITY>                 5,456,164
<SALES>                                        237,601
<TOTAL-REVENUES>                               237,601
<CGS>                                           52,167
<TOTAL-COSTS>                                   52,167
<OTHER-EXPENSES>                            15,121,006
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               9,141
<INCOME-PRETAX>                           (14,791,998)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                              (14,852,936)
<EPS-BASIC>                                     (1.46)
<EPS-DILUTED>                                   (1.46)